P M Bélanger

1.2k total citations
50 papers, 888 citations indexed

About

P M Bélanger is a scholar working on Pharmacology, Pharmacology and Molecular Biology. According to data from OpenAlex, P M Bélanger has authored 50 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 15 papers in Pharmacology and 13 papers in Molecular Biology. Recurrent topics in P M Bélanger's work include Pharmacogenetics and Drug Metabolism (23 papers), Metabolism and Genetic Disorders (8 papers) and Analytical Chemistry and Chromatography (7 papers). P M Bélanger is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Metabolism and Genetic Disorders (8 papers) and Analytical Chemistry and Chromatography (7 papers). P M Bélanger collaborates with scholars based in Canada, United Kingdom and United States. P M Bélanger's co-authors include Gaston Labrecque, A H Beckett, O Grech-Bélanger, Jacques Turgeon, François Doré, Bettina A. Hamelin, Andrew C. G. Uprichard, Dean W.G. Harron, Bernard Bruguerolle and M. R. Gilbert and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

P M Bélanger

50 papers receiving 845 citations

Peers

P M Bélanger
Karin Kramer Nielsen Denmark
Anthony G. Zacchei United States
Samuel A. Cucinell United States
David G. Kaiser United States
J.F. Ménez France
B. Norlander Sweden
Anthony J. Streeter United States
Noriko Ohashi Japan
H. Hücker United States
Karl H. Beyer United States
Karin Kramer Nielsen Denmark
P M Bélanger
Citations per year, relative to P M Bélanger P M Bélanger (= 1×) peers Karin Kramer Nielsen

Countries citing papers authored by P M Bélanger

Since Specialization
Citations

This map shows the geographic impact of P M Bélanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P M Bélanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P M Bélanger more than expected).

Fields of papers citing papers by P M Bélanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P M Bélanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P M Bélanger. The network helps show where P M Bélanger may publish in the future.

Co-authorship network of co-authors of P M Bélanger

This figure shows the co-authorship network connecting the top 25 collaborators of P M Bélanger. A scholar is included among the top collaborators of P M Bélanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P M Bélanger. P M Bélanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Ashish, Sylvie Pilote, P M Bélanger, Marie Arsenault, & Bettina A. Hamelin. (2004). A convenient five‐drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study. British Journal of Clinical Pharmacology. 58(3). 288–297. 32 indexed citations
2.
El‐Kadi, Ayman O.S., et al.. (1999). Effect of hypoxia alone or combined with inflammation and 3‐methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. British Journal of Pharmacology. 128(2). 365–373. 31 indexed citations
3.
4.
Lessard, Étienne, Anne Fortin, P M Bélanger, et al.. (1997). Role of CYP2D6 in the N-hydroxylation of procainamide. Pharmacogenetics. 7(5). 381–390. 20 indexed citations
5.
Turgeon, Jacques, et al.. (1992). Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination.. Drug Metabolism and Disposition. 20(5). 762–769. 22 indexed citations
6.
Labrecque, Gaston & P M Bélanger. (1991). Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacology & Therapeutics. 52(1). 95–107. 102 indexed citations
7.
Grech-Bélanger, O, et al.. (1991). Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation.. Drug Metabolism and Disposition. 19(2). 458–461. 10 indexed citations
8.
Turgeon, Jacques, Céline Fiset, Robert Giguère, et al.. (1991). Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 789–798. 53 indexed citations
9.
Labrecque, Gaston, et al.. (1990). Temporal Variation in the Effects of Warfarin on the Vitamin K Cycle. Chronobiology International. 7(5-6). 403–411. 10 indexed citations
10.
11.
Gillard, John W. & P M Bélanger. (1987). Metabolic synthesis of arylacetic acid antiinflammatory drugs from arylhexenoic acids. 2. Indomethacin. Journal of Medicinal Chemistry. 30(11). 2051–2058. 7 indexed citations
12.
Bélanger, P M, et al.. (1987). Time-dependent variations in the organ extraction ratios of acetaminophen in rat. Journal of Pharmacokinetics and Biopharmaceutics. 15(2). 133–143. 23 indexed citations
13.
Labrecque, Gaston, et al.. (1984). Chronobiological study of plasma exudation in carrageenan-paw oedema in the rat. Inflammation Research. 14(5-6). 719–722. 10 indexed citations
14.
Bélanger, P M, et al.. (1983). Rapid Gas Chromatographic Determination of Serum Salicylates After Silylation. Journal of Pharmaceutical Sciences. 72(9). 1092–1093. 11 indexed citations
15.
Bélanger, P M, et al.. (1981). Colorimetric determination of N-hydroxylated metabolites in microsomal studies. Analytical Biochemistry. 118(1). 47–52. 21 indexed citations
16.
Bélanger, P M, O Grech-Bélanger, & Robert F. Labadie. (1979). Depression of hepatic microsomal enzyme systems by amantadine hydrochloride in the rat.. Journal of Pharmacology and Experimental Therapeutics. 211(3). 485–490. 11 indexed citations
17.
Bélanger, P M & O Grech-Bélanger. (1979). Metabolic reduction of 1-nitrosoadamantane by rabbit liver microsomes. Properties of a C-nitroso reductase system.. Drug Metabolism and Disposition. 7(3). 171–175. 4 indexed citations
18.
Bélanger, P M & O Grech-Bélanger. (1977). The identification of the n oxidized metabolic products of amantadine in the rabbit. 12(4). 99–102. 3 indexed citations
19.
20.
Beckett, A H & P M Bélanger. (1975). Metabolic incorporation of oxygen into primary and secondary aliphatic amines and the consequences in carbon-nitrogen bond cleavage. Journal of Pharmacy and Pharmacology. 27(7). 547–552. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Kramer Nielsen Breakdown of academic impact, for papers by Anthony G. Zacchei Breakdown of academic impact, for papers by Samuel A. Cucinell Breakdown of academic impact, for papers by David G. Kaiser Breakdown of academic impact, for papers by J.F. Ménez Breakdown of academic impact, for papers by B. Norlander Breakdown of academic impact, for papers by Anthony J. Streeter Breakdown of academic impact, for papers by Noriko Ohashi Breakdown of academic impact, for papers by H. Hücker Breakdown of academic impact, for papers by Karl H. Beyer
Rankless by CCL
2026